Edgar Engleman insider trades: Bolt Biotherapeutics (BOLT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Edgar reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | BOLT | ↓ Sell | 130,819 | $0.87 | $113K | By Vivo Capital Fund VIII, L.P. | Dec 1, 2023 (1d) |
| Nov 30, 2023 | BOLT | ↓ Sell | 18,065 | $0.87 | $16K | By Vivo Capital Surplus Fund VIII, L.P. | Dec 1, 2023 (1d) |
| Nov 21, 2023 | BOLT | ↓ Sell | 1,707 | $0.90 | $2K | By Vivo Capital Fund VIII, L.P. | Nov 22, 2023 (1d) |
| Nov 21, 2023 | BOLT | ↓ Sell | 236 | $0.90 | $213 | By Vivo Capital Surplus Fund VIII, L.P. | Nov 22, 2023 (1d) |
| Nov 20, 2023 | BOLT | ↓ Sell | 43,207 | $0.93 | $40K | By Vivo Capital Fund VIII, L.P. | Nov 20, 2023 (0d) |
| Nov 20, 2023 | BOLT | ↓ Sell | 5,966 | $0.93 | $6K | By Vivo Capital Surplus Fund VIII, L.P. | Nov 20, 2023 (0d) |
| Feb 9, 2021 | BOLT | ↑ Buy | 175,733 | $20.00 | $3.5M | By Vivo Capital Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↑ Buy | 24,267 | $20.00 | $485K | By Vivo Capital Surplus Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↓ Sell | 144 | $20.00 | $3K | By Vivo Capital Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↓ Sell | 20 | $20.00 | $400 | By Vivo Capital Surplus Fund VIII, L.P. | Feb 9, 2021 (0d) |
| Dec 15, 2017 | SLNO | ↑ Buy | 1,085,480 | $1.84 | $2.0M | Indirect | Dec 19, 2017 (4d) |
| Mar 7, 2017 | CAPN | ↑ Buy | 1,410,461 | $0.96 | $1.4M | Indirect | Apr 14, 2017 (38d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BOLT insiders
Open-market trades in the last 12 months
About Edgar Engleman's insider trades
Edgar Engleman is a director at Bolt Biotherapeutics (BOLT). Since Mar 7, 2017, Edgar has reported 4 open-market purchases worth $7.4M and 8 sales worth $180K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), other transactions (7 filings), conversions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BOLT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.